# ADAKVEO
> **BLA761128** · Biologics License Application · Sponsor: NOVARTIS PHARMS CORP · Approved 2019-11-15
## Drug
- **FDA Application Number:** BLA761128
- **Application type:** Biologics License Application
- **Brand name:** ADAKVEO
- **Generic name:** CRIZANLIZUMAB
- **Active ingredients:** CRIZANLIZUMAB-TMCA
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** NOVARTIS PHARMS CORP
- **Manufacturer:** Novartis Pharmaceuticals Corporation
- **First approval:** 2019-11-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761128)
---
*AI Analytics · CC0 1.0*